Dimensional Fund Advisors
NRIX icon

Dimensional Fund Advisors’s Nurix Therapeutics NRIX Stock Holding History

Dimensional Fund Advisors’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Buy
780,696
+349,710
+81% +$5.8M ﹤0.01% 2188
2025
Q4 		$8.18M Buy
430,986
+24
+0% +$345 ﹤0.01% 2354
2025
Q3 		$3.98M Buy
430,962
+3,891
+0.9% +$40.4K ﹤0.01% 2604
2025
Q2 		$4.87M Sell
427,071
-148,241
-26% -$1.6M ﹤0.01% 2531
2025
Q1 		$6.84M Buy
575,312
+68,473
+14% +$1.15M ﹤0.01% 2399
2024
Q4 		$9.55M Buy
506,839
+5,270
+1% +$121K ﹤0.01% 2326
2024
Q3 		$11.3M Sell
501,569
-101,564
-17% -$2.3M ﹤0.01% 2251
2024
Q2 		$12.6M Sell
603,133
-363,320
-38% -$5.66M ﹤0.01% 2158
2024
Q1 		$14.2M Sell
966,453
-33,591
-3% -$361K ﹤0.01% 2159
2023
Q4 		$10.3M Buy
1,000,044
+42,001
+4% +$288K ﹤0.01% 2308
2023
Q3 		$7.53M Buy
958,043
+180,531
+23% +$1.65M ﹤0.01% 2383
2023
Q2 		$7.77M Buy
777,512
+143,995
+23% +$1.47M ﹤0.01% 2366
2023
Q1 		$5.63M Buy
633,517
+49,775
+9% +$519K ﹤0.01% 2448
2022
Q4 		$6.41K Buy
583,742
+249,017
+74% +$3M ﹤0.01% 2373
2022
Q3 		$4.36M Buy
334,725
+130,423
+64% +$2.06M ﹤0.01% 2474
2022
Q2 		$2.59M Sell
204,302
-33,223
-14% -$377K ﹤0.01% 2662
2022
Q1 		$3.33M Buy
237,525
+121,167
+104% +$2.15M ﹤0.01% 2666
2021
Q4 		$3.37M Buy
+116,358
New +$3.53M ﹤0.01% 2694

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Dimensional Fund Advisors's NRIX Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Nurix Therapeutics (NRIX) stake by 81% in Q1 2026, buying an estimated $5.8M and bringing the position to 780,696 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2188.

Dimensional Fund Advisors first reported a position in NRIX in Q4 2021 and has held it in 18 quarters since. The position peaked at $14.2M in Q1 2024. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Dimensional Fund Advisors held 780,696 shares of Nurix Therapeutics worth $12.1M as of Q1 2026.
  • Dimensional Fund Advisors bought 349,710 Nurix Therapeutics shares in Q1 2026, an estimated $5.8M.
  • Nurix Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2188 holding.
  • Dimensional Fund Advisors first reported a position in Nurix Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Dimensional Fund Advisors's Nurix Therapeutics position peaked at $14.2M in Q1 2024.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.